0001437749-19-024638.txt : 20191218
0001437749-19-024638.hdr.sgml : 20191218
20191218210703
ACCESSION NUMBER: 0001437749-19-024638
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191216
FILED AS OF DATE: 20191218
DATE AS OF CHANGE: 20191218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pellegrino Joseph P JR
CENTRAL INDEX KEY: 0001365733
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33092
FILM NUMBER: 191293979
MAIL ADDRESS:
STREET 1: 68 BEACON STREET
CITY: BOSTON
STATE: MA
ZIP: 02108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LEMAITRE VASCULAR INC
CENTRAL INDEX KEY: 0001158895
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 63 SECOND AVENUE
CITY: BURLINGTON
STATE: MA
ZIP: 01803
BUSINESS PHONE: 781-221-2266
MAIL ADDRESS:
STREET 1: 63 SECOND AVENUE
CITY: BURLINGTON
STATE: MA
ZIP: 01803
4
1
rdgdoc.xml
FORM 4
X0306
4
2019-12-16
0001158895
LEMAITRE VASCULAR INC
LMAT
0001365733
Pellegrino Joseph P JR
C/O LEMAITRE VASCULAR, INC.
63 SECOND AVENUE
BURLINGTON
MA
01803
1
1
Chief Financial Officer
Common Stock
2019-12-16
4
S
0
6068
36.1742
D
41491
D
Common Stock
2019-12-18
4
S
0
10442
36.09780
D
31049
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan established by the Reporting Person.
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $36.00 to $36.40. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $36.00 to $36.35. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
/s/ Laurie A. Churchill, Attorney-in-fact
2019-12-18